Predictive factors affecting mobilization and peripheral blood stem cell (PBSC) collection using single apheresis (SA) for rescuing patients after high-dose chemotherapy (HD.CHE) in various malignancies

Bone Marrow Transplantation

Volumn 18, Issue 6, 1996, Pages 1065-1072

  Koumakis, G ^a   Vassilomanolakis, M ^a   Hatzichristou, H ^a   Barbounis, V ^a   Filis, J ^a   Papanastasiou, K ^a   Moraki, M ^a   Kritsioti, M ^a   Plataniotis, G ^a   Stamatelou, M ^a   Efremidis, A P ^a,b  

^a SAINT SAVVAS HOSPITAL   (Greece)

^b MOUNT SINAI HOSPITAL   (United States)

Author keywords

Peripheral blood stem cells; Single apheresis; Stem cell transplantation

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CARMUSTINE; CD34 ANTIGEN; CHLORAMBUCIL; CHLORMETHINE; CISPLATIN; COLONY STIMULATING FACTOR; CYCLOPHOSPHAMIDE; CYTARABINE; DACARBAZINE; DOXORUBICIN; ETOPOSIDE; FLUOROURACIL; MELPHALAN; PREDNISOLONE; PROCARBAZINE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; RECOMBINANT GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; VINBLASTINE; VINCRISTINE;

ADOLESCENT; ADULT; AGED; ARTICLE; BONE MARROW; CANCER CELL; CANCER INFILTRATION; CLINICAL TRIAL; COLONY FORMING UNIT; CYTAPHERESIS; FEMALE; HUMAN; HUMAN CELL; LEUKEMIA; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; PERIPHERAL BLOOD STEM CELL; PRIORITY JOURNAL; REGRESSION ANALYSIS; SOLID TUMOR; STEM CELL TRANSPLANTATION; SUBCUTANEOUS DRUG ADMINISTRATION; TREATMENT PLANNING;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ANTINEOPLASTIC AGENTS, ALKYLATING; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLOOD CELL COUNT; BONE MARROW; BONE MARROW DISEASES; CYCLOPHOSPHAMIDE; FEMALE; HEMATOPOIETIC CELL GROWTH FACTORS; HEMATOPOIETIC STEM CELLS; HUMANS; LEUKAPHERESIS; MALE; MIDDLE AGED; NEOPLASMS; RADIOTHERAPY;

EID: 0030470728     PISSN: 02683369     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Fruehauf B, Rainer H, Conradt C et al. Peripheral blood progenitor cell (PBPC) counts during steady-state hematopoiesis allow to estimate the yield of mobilized PBPC after filgrastim (R-met HuG-CSF)-supported cytotoxic chemotherapy. Blood 1995; 85: 2619-2626.
2. Juttner CA, To LB, Haylock DN et al. The threshold effect in peripheral blood stem cell autografting - differences between acute myeloid leukemia and non-stem cell diseases. Exp Hematol 1989; 17: 357a.
3. Gianni A, Siena S, Bregni M et al. Factors influencing the yield of circulating hemopoietic progenitor cells harvested from cancer patients after high dose cyclophosphamide treatment with or without rH GM-CSF infusion. 16th Annual Meeting of EBMT. The integrated Sandoz/Schering-Plough Symposium, The Hague, The Netherlands, 1990, 20.
4. Shpall EJ, Jones RB, Bearmen SI et al. Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high dose chemotherapy: influence of CD34-positive peripheral blood progenitors and growth factors on engraftment. J Clin Oncol 1994; 12: 28-36.
5. Brugger W, Henchler R, Heimfeld S et al. Positively selected autologous blood CD34+ cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high dose VP16, ifosphamide, carboplatin and epirubicin. Blood 1994; 84: 1421-1426.
6. Koumakis G, Filis J, Vassilomanolakis M et al. Relation between haematological recovery and number of transplanted mononuclear cells in patients after high dose chemotherapy (H.D.CHE) with peripheral blood stem cell (PBSC) rescue. Blood Cells Mol Dis 1995; 21: 240-243.
7. Kessinger A, Armitage JO. The role of autologous peripheral stem cell transplantation following high dose therapy for malignancies. Blood 1991; 77: 211-213.
8. Bensinger WI, Longin K, Appelbaum F et al. Peripheral blood stem cells (PBSCs) collected after recombinant granulocyte colony stimulating factor (rhG-CSF): an analysis of factors correlating with the tempo of engraftment after transplantation. Br J Haematol 1994; 87: 825-831.
9. Sheridan WP, Morstyn G, Wolf M et al. Granulocyte colony-stimulating factor and neutrophil recovery after high-dose chemotherapy and autologous bone marrow transplantation. Lancet 1989; 2: 891-895.
10. Rosti G, Albertazzi L, Lasset C et al. High-dose chemotherapy with ABMT-PBSCT in breast cancer in Europe in 1993. 20th Annual Meeting of the European Group for Bone Marrow Transplantation, Harrogate, 1994, 137 (Abstr. 169).
11. Pettengell R, Morgenstern GR, Woll PJ et al. Peripheral blood progenitor cell transplantation in lymphoma and leukemia using a single apheresis. Blood 1993; 82: 3770-3777.
12. Jones HM, Jones SA, Watts MJ et al. Development of a simplified single-apheresis for peripheral blood progenitor cell transplantation in previously treated patients with lymphoma. J Clin Oncol 1994; 12: 1693-1702.
13. Efremidis AP, Koumakis G, Fills J et al. Peripheral blood progenitor cells (PBPC) transplantation with a single apheresis in various malignancies. Bone Marrow Transplant 1996: 17: 673-674.
14. Kotasec D, Shepherd KM, Sage RE et al. Factors affecting blood stem cell collections following high dose cyclophosphamide mobilization in lymphoma, myeloma and solid tumors. Bone Marrow Transplant 1992; 9: 11-17.
15. Haas R, Moble R, Fruhauf S et al. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 1994; 83: 3787-3794.
16. Passos-Coelho JL, Braine HG, Davis JM et al. Predictive factors for peripheral blood progenitor cell collections using a single large-volume leukapheresis after cyclophosphamide and granulocyte macrophage colony-stimulating factor mobilization. J Clin Oncol 1995; 13: 705-714.
17. Bensinger W, Appelbaum F, Rowley S et al. Factors that influence collection and engraftment of autologous peripheralblood stem cells. J Clin Oncol 1995; 13; 2547-2555.
18. Efremidis AP, Haubenstock H, Holland JF et al. TPA-induced maturation in secretory human B-leukemic cells in vitro. DNA synthesis, antigenic changes and immunoglobin secretion. Blood 1985; 6: 953-960.
19. Shepherd M, Charles P, Sager E et al. Mobilization of haemopoietic stem cells by cyclophosphamide into the peripheral blood of patients with haematological malignancies. Clin Lab Haematol 1991; 13: 25-32.